4 completed, 1 recruiting, 1 unknown. 2 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Atopic Disorders: new trials by email Literature Review of Atopic Disorders trials Research Report on Atopic Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Atopy Network - Comprehensive Allergy Centers: Medical Care of Patients With Moderate to Severe Allergic Diseases not applicable, observational study - Atopic Disorders | Recruiting | Charite University, Berlin, Germany | 600 | 2022-12-08 | 2026-10-21 | |
| Skin Tolerance of Medical Devices for Diabetes Monitoring and Treatment in Children With Type 1 Diabetes questionary - Cutaneous Allergy, Diabetes Mellitus, Type 1 | Unknown | Central Hospital, Nancy, France | 400 | 2022-05-15 | 2023-07-06 | |
| Atopic Diseases & Human Papilloma Virus HPV test results - Human Papilloma Virus, Atopic Asthma | Completed | Adana Numune Training and Research Hospital | 239 | 2019-08-01 | 2020-05-26 | |
| A Community-based Assessment of Skin Care, Allergies, and Eczema Participant choice of over-the-counter emollients: Vaseline, Vanicream, CeraVe Healing Ointment, CeraVe cream, Cetaphil cream - Atopic Dermatitis, Atopic Disorders | Not applicable | Completed | Oregon Health and Science University | 1260 | 2018-07-16 | 2025-08-15 |
| Effect of Modified Playground Environment on Health, Particularly Immune System Biodiversity powder, Placebo - Atopic Disorders, Immune System Diseases | Not applicable | Completed | University of Helsinki | 25 | 2018-04-15 | 2019-06-25 |
| Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis Dupilumab, Auto-injector Device, Prefilled syringe - Atopic Disorders, Eczema, Atopic | Phase 1 | Completed | Regeneron Pharmaceuticals | 176 | 2017-02-28 | 2018-08-01 |
Dermatitis, Atopic (2) · Asthma (1) · Diabetes Mellitus, Type 1 (1) · Eczema (1) · Immune System Diseases (1) · Rhinitis (1) · Urticaria (1)
Immune System Diseases (4) · Hypersensitivity (3) · Hypersensitivity, Immediate (3) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Dermatitis (2) · Genetic Diseases, Inborn (2) · Skin Diseases, Eczematous (2) · Skin Diseases, Genetic (2) · Autoimmune Diseases (1) · Bronchial Diseases (1) · Diabetes Mellitus (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1)
Observation (1) · dupilumab (1)
Adana Numune Training and Research Hospital (1) · Central Hospital, Nancy, France (1) · Charite University, Berlin, Germany (1) · Oregon Health and Science University (1) · Regeneron Pharmaceuticals (1) · University of Helsinki (1)
United States (2) · Finland (1) · France (1) · Germany (1) · Turkey (Türkiye) (1)
Aki Sinkkonen, ph d (1) · Eric Simpson, MD (1) · Gulsum Uysal (1) · Margitta Worm, Prof. (1)
PMID 32131885, PMID 35567671, PMID 40699587
R01AR071057 (1)